EUVIMEDEUVIMED entdecken
Open Access

Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8 + - T cell-mediated anti-tumor immunity

Xin Xin, Zhao Li, Xuanxuan Yan, Ting Liu, Zuyin Li, Zhuomiaoyu Chen, Xinlong Yan, Fanxin Zeng, Lingling Hou, Jinhua Zhang

Theranostics · 2024

DOI: 10.7150/thno.97276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Xin Xin und 9 weiteren Autor:innen. Beteiligte Einrichtung: The College of Life Science and Bioengineering, Beijing Jiaotong University, Beijing, China. Hauptthemen laut MEDLINE: Carcinogenesis, Carcinoma, Hepatocellular, CD8-Positive T-Lymphocytes, Chemokine CXCL10. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinogenesisCarcinoma, HepatocellularCD8-Positive T-LymphocytesChemokine CXCL10HepatocytesLiver NeoplasmsReceptors, CXCR3AnimalsHumansMaleMiceMice, Inbred C57BLMice, KnockoutSignal TransductionSmad4 Protein

Stichwörter der Autor:innen

CXCL10, aerobic glycolysishepatocellular carcinomahepatocyte, Smad4

Substanzen

Chemokine CXCL10Cxcl10 protein, mouseCxcr3 protein, mouseReceptors, CXCR3Smad4 ProteinSmad4 protein, mouse

Autor:innen und Institutionen

  • The College of Life Science and Bioengineering, Beijing Jiaotong University, Beijing, China.
  • Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing, China.
  • School of Life Science and Technology, Jinan University, Guangzhou, Guangdong province, China.
  • Faculty of Environmental and Life Sciences, Beijing University of Technology, Beijing, China.
  • Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan province, China.

Zitieren

APA

Xin, X., Li, Z., Yan, X., Liu, T., Li, Z., Chen, Z., Yan, X., Zeng, F., Hou, L., & Zhang, J. (2024). Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8 + - T cell-mediated anti-tumor immunity. Theranostics. https://doi.org/10.7150/thno.97276

Vancouver

Xin X, Li Z, Yan X, Liu T, Li Z, Chen Z, et al. Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8 + - T cell-mediated anti-tumor immunity. Theranostics. 2024. doi:10.7150/thno.97276

BibTeX
@article{Xin2024,
  author = {Xin, Xin and Li, Zhao and Yan, Xuanxuan and Liu, Ting and Li, Zuyin and Chen, Zhuomiaoyu and Yan, Xinlong and Zeng, Fanxin and Hou, Lingling and Zhang, Jinhua},
  title = {Hepatocyte-specific Smad4 deficiency inhibits hepatocarcinogenesis by promoting CXCL10/CXCR3-dependent CD8 + - T cell-mediated anti-tumor immunity},
  journal = {Theranostics},
  year = {2024},
  doi = {10.7150/thno.97276}
}
Kostenlos starten →